Exhibit 99.2
Crowe MacKay LLP
1100 - 1177 West Hastings St. Vancouver, BC V6E 4T5 Main +1 (604) 687-4511 Fax +1 (604) 687-5805
www.crowemackay.ca |
October 22, 2021
British Columbia Securities Commission
Alberta Securities Commission
Financial and Consumer Affairs Authority of Saskatchewan
The Manitoba Securities Commission
Ontario Securities Commission
New Brunswick Financial and Consumer Services Commission
Nova Scotia Securities Commission
Prince Edward Island Office of the Superintendent of Securities
Superintendent of Securities (Newfoundland and Labrador)
Dear Sirs and Mesdames:
Re: | ImmunoPrecise Antibodies Ltd. (the “Company”) – Change of Auditor |
In accordance with Section 4.11 of National Instrument 51-102 - Continuous Disclosure Obligations, we have reviewed the information contained in the Company’s Notice of Change of Auditor dated October 13, 2021, (the “Notice”) and agree with the information contained therein, based upon our knowledge of the information relating to the said Notice and of the Company at this time.
We understand that the Notice, along with this letter and a similar letter from Grant Thornton LLP, will be provided to the Company’s registered shareholders with the meeting materials relating to the Company’s next Annual General Meeting of Shareholders.
Yours truly, |
/s/ “Crowe MacKay LLP” |
Crowe MacKay LLP |
Chartered Professional Accountants |